The deal is the synergy you can defend minus the integration you will actually do. Everything else is a press release.
Buying a competitor is a right-to-win on their book plus a realistic cost to integrate. Synergies that assume customers, people, and systems combine cleanly are how deals destroy value. If the same cash used on the core still returns more after honest integration cost, do not buy.
The move that usually makes it worse: Doing the deal to 'not be left out' while the core still has unpaid-back work.
Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures.
If it is your problem and you want the analysis on your numbers, the live page is https://percision.app/should-we-buy-a-competitor. The engine routes this question to M&A screening. Metrics that decide it: synergy realism · integration cost.
Industry variants: Professional services · Banks & financial services · Healthcare providers · Healthtech / digital health · Logistics & supply chain · E-commerce & DTC · Manufacturing · Construction & trades · Retail · Real estate & property · Fintech
It can screen whether the thesis survives arithmetic and name the kill criteria. Legal, quality-of-earnings, and cultural diligence are human work.
Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures.
No. A cheap competitor with a worse-margin book is how you import their problem.